Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

value

- PMLiVE

What’s on the horizon?

The evolving role of the healthcare expert.

- PMLiVE

Hanover Health opens market access practice

New practice will be led by director Jing Wang-Silvanto

- PMLiVE

Novartis’ former UK government affairs head launches consultancy

Oxygen Strategy will offer pharma clients a 'fresh approach to strategy'

- PMLiVE

A New View

Creating value is key to the future of marketing

- PMLiVE

Making a list and checking it twice…

The promise of mobile health lies not in recording information but in promoting behaviour change

- PMLiVE

PC: Patient-centricity or merely politically correct?

It is time that pharma started prioritising patient-centricity activities, so that the concept becomes something that patients notice and benefit from, rather than just a mantra

- PMLiVE

Global drug spending will rise by a third to $1.5trn in 2021

However, rate of growth will not match previous years due to pricing and access pressures

- PMLiVE

Pfizer gets record £84m fine for hiking price of epilepsy drug

US firm plans to appeal after CMA finds it raised NHS fee by 2,600% in 2012

- PMLiVE

Real-world evidence

Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

- PMLiVE

Healthcare and the artificial intelligence revolution

How technologists and healthcare professionals are working together to improve patient outcomes

- PMLiVE

An exciting outlook for pre-approval access and compassionate use

How to deal with the ethical and practical considerations of the demand for promising new drugs that are in development

- PMLiVE

Ono faces steep price cut for Opdivo in Japan

Japanese regulator proposes 50% cut after drug’s population growth exceeds initial projections

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links